Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: Histologically proven invasive breast carcinoma. Patients who underwent staging or response evaluation imaging (PET/CT) Imaging evidence of metastatic involvement of IMNs (pathology or PET-avid).
Exclusion criteria
Exclusion criteria: Patients with prior non-breast malignancies involving mediastinal nodes. Inadequate imaging quality or missing essential data for nodal mapping. Patients who received prior radiotherapy to the mediastinum.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the distribution pattern of internal mammary nodal (IMN) metastases in breast cancer patients across early, locally advanced, and metastatic stagesTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the coverage of involved IMNs by standard radiotherapy atlases (RTOG, ESTRO, RADCOMP).Timepoint: at 1 year | — |
Countries
India
Contacts
Public ContactDr Budhi Singh Yadav
Post Graduate Institute of Medical Education and Research
Outcome results
None listed